Diagnostic and prognostic role of cardiac troponin I (cTnI) measured on the DPC Immulite

Clinical Biochemistry

Volumn 39, Issue 7, 2006, Pages 692-696

  Collinson, P O ^a   Gaze, D C ^a   Stubbs, P J ^b   Swinburn, J ^b   Khan, M ^b   Senior, R ^b   Lahiri, A ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Chest pain; Myocardial infarction; Prognostic risk assessment; Troponin

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANALYZER; ARTICLE; BLOOD SAMPLING; CARDIOLOGY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; EUROPE; FEMALE; FOLLOW UP; HEART DEATH; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL SOCIETY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; RISK ASSESSMENT; SERUM; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOM; THORAX PAIN; VENOUS CIRCULATION; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CORONARY DISEASE; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; TROPONIN I;

EID: 33745849738     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.02.006     Document Type: Article

References (16)

1. Bertrand M.E., Simoons M.L., Fox K.A., Wallentin L.C., Hamm C.W., McFadden E., et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 23 (2002) 1809-1840
2. Myocardial infarction redefined-A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur. Heart J. 21 (2000) 1502-1513
3. Boersma E., Harrington R.A., Moliterno D.J., White H., Theroux P., Van de W.F., et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 359 (2002) 189-198
4. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N. Engl. J. Med. 344 (2001) 1879-1887
5. Hafner G., Peetz D., Erbes H., Post F., Dahm M., Peivandi A.A., et al. Comparison of diagnostic performance of cardiac troponin I on the IMMULITE system with other automated troponin I assays in minor myocardial damage. Scand. J. Clin. Lab. Invest. 61 (2001) 227-235
6. Lestin M., Hergert M., Lestin H.G., Brinker C., Storm H., Kuhrt E., et al. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems. Clin. Lab. 48 (2002) 211-221
7. Kaul S., Senior R., Firschke C., Wang X.Q., Lindner J., Villanueva F.S., et al. Incremental value of cardiac imaging in patients presenting to the emergency department with chest pain and without ST-segment elevation: a multicenter study. Am. Heart J. 148 (2004) 129-136
8. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 59 (1979) 607-609
9. Collinson P.O., Stubbs P.J., and Kessler A.C. Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice. Heart 89 (2003) 280-286
10. Rao A.C., Collinson P.O., Canepa-Anson R., and Joseph S.P. Troponin T measurement after myocardial infarction can identify left ventricular ejection of less than 40%. Heart 80 (1998) 223-225
11. Rao A.C., Collinson P.O., Rose A.J., John C., Canepa-Anson R., and Joseph S.P. Prospective evaluation of the role of routine cardiac troponin T measurement to identify left ventricular ejection fraction <40% after first myocardial infarction. Heart 89 (2003) 559-560
12. James S., Armstrong P., Califf R., Simoons M.L., Venge P., Wallentin L., et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am. J. Med. 115 (2003) 178-184
13. Antman E.M., Tanasijevic M.J., Thompson B., Schactman M., McCabe C.H., Cannon C.P., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. [see comments]. N. Engl. J. Med. 335 (1996) 1342-1349
14. Lindahl B., Venge P., and Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. [see comments]. Circulation 93 (1996) 1651-1657
15. Ooi D.S., Isotalo P.A., and Veinot J.P. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin. Chem. 46 (2000) 338-344
16. Collinson P.O., and Stubbs P.J. Are troponins confusing?. Heart 89 (2003) 1285-1287